Salud financiera de hoja de balance de Alector
Salud financiera controles de criterios 6/6
Alector tiene un patrimonio de los accionistas total de $134.2M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $621.8M y $487.7M respectivamente.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
Ratio de cobertura de intereses | n/a |
Efectivo | US$562.08m |
Patrimonio | US$178.91m |
Total pasivo | US$456.59m |
Activos totales | US$635.49m |
Actualizaciones recientes sobre salud financiera
Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Sep 25Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Jun 27Alector (NASDAQ:ALEC) Is In A Good Position To Deliver On Growth Plans
Jan 16We're Not Very Worried About Alector's (NASDAQ:ALEC) Cash Burn Rate
Sep 27Recent updates
Alector, Inc. (NASDAQ:ALEC) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 11Analysts Are Updating Their Alector, Inc. (NASDAQ:ALEC) Estimates After Its Full-Year Results
Mar 01The Market Doesn't Like What It Sees From Alector, Inc.'s (NASDAQ:ALEC) Revenues Yet As Shares Tumble 27%
Jan 19Alector: Good Data, Huge Cash, No Near Term Catalyst
Jan 16Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Sep 25Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Jun 27Analysts Are Betting On Alector, Inc. (NASDAQ:ALEC) With A Big Upgrade This Week
Mar 02Alector (NASDAQ:ALEC) Is In A Good Position To Deliver On Growth Plans
Jan 16Alector: Advancement Of Third Alzheimer's Drug Brings About Huge Potential
Oct 04AbbVie ends partnership with Alector for Alzheimer’s candidate
Jul 08Alector: Potential In Neurology And Cancer Treatments
Jun 14Need To Know: The Consensus Just Cut Its Alector, Inc. (NASDAQ:ALEC) Estimates For 2022
May 18Alector: Expect Phase 3 Data Next Year
Apr 16These Analysts Just Made An Downgrade To Their Alector, Inc. (NASDAQ:ALEC) EPS Forecasts
Feb 27Alector, Inc: A Newer Biotech Company With Big Potential
Jan 26Alector: The GSK Deal Is A Major Value Add
Oct 29We're Not Very Worried About Alector's (NASDAQ:ALEC) Cash Burn Rate
Sep 27This Just In: Analysts Are Boosting Their Alector, Inc. (NASDAQ:ALEC) Outlook for This Year
Aug 05New Forecasts: Here's What Analysts Think The Future Holds For Alector, Inc. (NASDAQ:ALEC)
Jul 06Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($565.8M) de ALEC superan a sus pasivos a corto plazo ($177.9M).
Pasivo a largo plazo: Los activos a corto plazo de ALEC ($565.8M) superan a sus pasivos a largo plazo ($309.7M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ALEC está libre de deudas.
Reducción de la deuda: ALEC no ha tenido ninguna deuda en los últimos 5 años.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: ALEC tiene suficiente cash runway para más de un año basándose en su flujo de caja libre actual.
Pronóstico de cash runway: ALEC dispone de suficiente cash runway para más de 3 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 7.7% cada año